No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Stock

CEO Monthly Awards 2025 Recognizes AXREM for Double Achievement

by
November 25, 2025
in Stock
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

AXREM, the UK’s leading trade association for medical imaging, radiotherapy, and healthcare IT, has recently received two prestigious accolades in the 2025 CEO Monthly Awards. The association’s CEO, Sally Edgington, was recognized as the Most Influential CEO 2025 in Industry Leadership (United Kingdom), while AXREM itself was named the Best MedTech Trade Association 2025 in the UK.

Source

Previous Post

Sir Richard Branson announces death of his wife Joan after 50 years of marriage

Next Post

“Forgotten Generation”: Music for Dementia and University of Sheffield Host Roundtable to Address Musical Exclusion in Dementia Community

Next Post

“Forgotten Generation”: Music for Dementia and University of Sheffield Host Roundtable to Address Musical Exclusion in Dementia Community

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

New working paper: “Shifting Perspectives: An Updated Survey of Environmental and Natural Resource Economists”

May 5, 2025

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023
Regulatory Preemption or Patchwork? What’s at Risk for AI Innovation and Consumers

Regulatory Preemption or Patchwork? What’s at Risk for AI Innovation and Consumers

0

0

0

0
Regulatory Preemption or Patchwork? What’s at Risk for AI Innovation and Consumers

Regulatory Preemption or Patchwork? What’s at Risk for AI Innovation and Consumers

November 25, 2025
America’s Children Are Unwell, Says NYT—School Choice Should be Part of the Solution.

America’s Children Are Unwell, Says NYT—School Choice Should be Part of the Solution.

November 25, 2025
Is the government intent on killing London’s hospitality sector with a double-whammy tourist tax?

Is the government intent on killing London’s hospitality sector with a double-whammy tourist tax?

November 25, 2025

“Forgotten Generation”: Music for Dementia and University of Sheffield Host Roundtable to Address Musical Exclusion in Dementia Community

November 25, 2025

Recent News

Regulatory Preemption or Patchwork? What’s at Risk for AI Innovation and Consumers

Regulatory Preemption or Patchwork? What’s at Risk for AI Innovation and Consumers

November 25, 2025
America’s Children Are Unwell, Says NYT—School Choice Should be Part of the Solution.

America’s Children Are Unwell, Says NYT—School Choice Should be Part of the Solution.

November 25, 2025
Is the government intent on killing London’s hospitality sector with a double-whammy tourist tax?

Is the government intent on killing London’s hospitality sector with a double-whammy tourist tax?

November 25, 2025

“Forgotten Generation”: Music for Dementia and University of Sheffield Host Roundtable to Address Musical Exclusion in Dementia Community

November 25, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.